[HTML][HTML] Development of a standardized chemiluminescence immunoassay for the detection of autoantibodies against human M-type phospholipase A2 receptor in …
C Dähnrich, S Saschenbrecker, I Gunnarsson… - Kidney International …, 2020 - Elsevier
Introduction Autoantibodies against the M-type phospholipase A2 receptor (PLA2R) are
important markers in the diagnosis and monitoring of primary membranous nephropathy …
important markers in the diagnosis and monitoring of primary membranous nephropathy …
[HTML][HTML] Development of a Standardized Chemiluminescence Immunoassay for the Detection of Autoantibodies Against Human M-Type Phospholipase A2 Receptor …
C Dähnrich, S Saschenbrecker… - Kidney International …, 2020 - ncbi.nlm.nih.gov
Methods Sera from 155 patients with biopsy-proven pMN and 154 disease controls were
analyzed for autoantibodies against PLA2R by the novel ChLIA as well as by ELISA and RC …
analyzed for autoantibodies against PLA2R by the novel ChLIA as well as by ELISA and RC …
[HTML][HTML] Development of a Standardized Chemiluminescence Immunoassay for the Detection of Autoantibodies Against Human M-Type Phospholipase A2 Receptor …
C Dähnrich, S Saschenbrecker, I Gunnarsson… - Kidney International …, 2020 - kireports.org
Introduction Autoantibodies against the M-type phospholipase A2 receptor (PLA2R) are
important markers in the diagnosis and monitoring of primary membranous nephropathy …
important markers in the diagnosis and monitoring of primary membranous nephropathy …
[PDF][PDF] Development of a Standardized Chemiluminescence Immunoassay for the Detection of Autoantibodies Against Human M-Type Phospholipase A2 Receptor in …
C Dähnrich, S Saschenbrecker, I Gunnarsson… - 2019 - scienceopen.com
Methods: Sera from 155 patients with biopsy-proven pMN and 154 disease controls were
analyzed for autoantibodies against PLA2R by the novel ChLIA as well as by ELISA and RC …
analyzed for autoantibodies against PLA2R by the novel ChLIA as well as by ELISA and RC …
Development of a Standardized Chemiluminescence Immunoassay for the Detection of Autoantibodies Against Human M-Type Phospholipase A2 Receptor in …
C Dähnrich, S Saschenbrecker… - Kidney International …, 2019 - europepmc.org
Methods Sera from 155 patients with biopsy-proven pMN and 154 disease controls were
analyzed for autoantibodies against PLA2R by the novel ChLIA as well as by ELISA and RC …
analyzed for autoantibodies against PLA2R by the novel ChLIA as well as by ELISA and RC …
Development of a Standardized Chemiluminescence Immunoassay for the Detection of Autoantibodies Against Human M-Type Phospholipase A2 Receptor in …
C Dähnrich, S Saschenbrecker… - Kidney …, 2020 - hal.sorbonne-universite.fr
Introduction: Autoantibodies against the M-type phospholipase A2 receptor (PLA2R) are
important markers in the diagnosis and monitoring of primary membranous nephropathy …
important markers in the diagnosis and monitoring of primary membranous nephropathy …
Development of a Standardized Chemiluminescence Immunoassay for the Detection of Autoantibodies Against Human M-Type Phospholipase A2 Receptor in …
C Dähnrich, S Saschenbrecker… - Kidney …, 2019 - pubmed.ncbi.nlm.nih.gov
Introduction Autoantibodies against the M-type phospholipase A2 receptor (PLA2R) are
important markers in the diagnosis and monitoring of primary membranous nephropathy …
important markers in the diagnosis and monitoring of primary membranous nephropathy …
Development of a Standardized Chemiluminescence Immunoassay for the Detection of Autoantibodies Against Human M-Type Phospholipase A2 Receptor in …
C Dähnrich, S Saschenbrecker, I Gunnarsson… - Kidney International …, 2020 - hal.science
Introduction: Autoantibodies against the M-type phospholipase A2 receptor (PLA2R) are
important markers in the diagnosis and monitoring of primary membranous nephropathy …
important markers in the diagnosis and monitoring of primary membranous nephropathy …
[PDF][PDF] Development of a Standardized Chemiluminescence Immunoassay for the Detection of Autoantibodies Against Human M-Type Phospholipase A2 Receptor in …
C Dähnrich, S Saschenbrecker, I Gunnarsson… - 2019 - hal.sorbonne-universite.fr
Methods: Sera from 155 patients with biopsy-proven pMN and 154 disease controls were
analyzed for autoantibodies against PLA2R by the novel ChLIA as well as by ELISA and RC …
analyzed for autoantibodies against PLA2R by the novel ChLIA as well as by ELISA and RC …